BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Honokiol

76+ PubMed studies analyzed · Evidence Score: 24.7

Research Domains

Honokiol has been studied across 20 research domains including 🔬 Oncology, 🔬 Inflammation, 🫁 Liver & Detox, ⏳ Longevity & Aging, 🧠 Neuroprotection. The primary research focus is 🔬 Oncology with 43% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Honokiol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

methylhonokiol
2 shared targets
win
2 shared targets
sr
2 shared targets
delta
2 shared targets
ibipinabant
2 shared targets
nabilone
2 shared targets
rac
2 shared targets
emindole
2 shared targets
dexanabinol
2 shared targets
otenabant
2 shared targets
Loading evidence profile...

This evidence profile for Honokiol is generated deterministically from 76 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.